HeartWare expands pivotal bridge-to-transplant trial
This article was originally published in Clinica
Executive Summary
HeartWare International is to enrol an additional 54 patients in its ADVANCE trial assessing its ventricular assist system as a bridge-to-transplant therapy in patients with end-stage heart failure.